# Avalyn Pharma Inc.: filings

AVLN · Nasdaq · CIK 1540171 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avln.md) · [Financials](/companies/avln/financials.md) · [Filings](/companies/avln/filings.md) · [Insiders](/companies/avln/insiders.md)

## Reports and events: 13 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (3 16, 4 15, 8-K 6, D 4, SCHEDULE 13G 4, D/A 3, 10-Q 2, S-1/A 2, SCHEDULE 13D 2, 424B4 1, 8-A12B 1, CERT 1, DRS 1, DRS/A 1, EFFECT 1, S-1 1, S-8 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-16 | 16:13 ET | [8-K](/filings/0001193125-26-393081.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-393081 |
| 2026-08-12 | 08:15 ET | [10-Q](/filings/0001193125-26-345820.md) | Quarterly report, period 2026-06-30 | 0001193125-26-345820 |
| 2026-08-12 | 08:06 ET | [8-K](/filings/0001193125-26-345807.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-345807 |
| 2026-07-01 | 17:20 ET | [8-K](/filings/0001193125-26-292834.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-292834 |
| 2026-06-17 | 08:03 ET | [8-K](/filings/0001193125-26-273405.md) | 7.01 Regulation FD disclosure | 0001193125-26-273405 |
| 2026-06-03 | 08:00 ET | [10-Q](/filings/0001193125-26-254623.md) | Quarterly report, period 2026-03-31 | 0001193125-26-254623 |
| 2026-06-03 | 07:25 ET | [8-K](/filings/0001193125-26-254581.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-254581 |
| 2026-05-08 | 18:52 ET | [SCHEDULE 13D](/filings/0000899140-26-000428.md) | Ownership report, active investor | 0000899140-26-000428 |
| 2026-05-08 | 16:41 ET | [SCHEDULE 13D](/filings/0001072613-26-000386.md) | Ownership report, active investor | 0001072613-26-000386 |
| 2026-05-01 | 16:09 ET | [8-K](/filings/0001193125-26-201434.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-201434 |
| 2026-04-29 | 09:29 ET | [S-1/A](/filings/0001193125-26-189477.md) | Registration statement, amended | 0001193125-26-189477 |
| 2026-04-23 | 16:01 ET | [S-1/A](/filings/0001193125-26-173632.md) | Registration statement, amended | 0001193125-26-173632 |
| 2026-04-08 | 16:01 ET | [S-1](/filings/0001193125-26-147573.md) | Registration statement | 0001193125-26-147573 |

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. No prices; not investment advice.